Maxzimaa Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Azadpur, Delhi, India, established in 2014.
2014 Azadpur, Delhi, India Active
Last Updated:
Access Report
About Maxzimaa Pharmaceuticals Private Limited

Maxzimaa Pharmaceuticals Private Limited, a active private limited company, was established on 30 December 2014 in Azadpur, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24100DL2014PTC274793. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹2.50 M.

It upholds a compliant status. Employing 57 professional, Its leadership includes Sucheta Dhawan (Director), Dhiraj Joshi (Director), Lovpreet Moti (Director). Past directors included Shweta Pathak, Rachana Khatri, Prabhu Jyot Singh. It holds ₹4.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 403, Amber Tower, 4Th Floor, Azadpur Commercial Complex,, Azadpur, Delhi, 110033.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100DL2014PTC274793

  • Registration Number

    274793

  • Incorporation Date

    30 December 2014

  • Authorized Capital

    ₹5.00 M

  • Paid-Up Capital

    ₹2.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 2.50 M
  • Company Age 11 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.50 M
  • Revenue Growth **** 36.08%
  • Profit Growth **** 2425.57%
  • Ebitda **** 181.84%
  • Net Worth 1.65%
  • Total Assets **** 44.53%
Company report

Maxzimaa Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Maxzimaa Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Maxzimaa Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Sucheta Dhawan Director 20 Jan 2015 Current
Dhiraj Joshi Director 20 Jan 2015 Current
Lovpreet Moti Director 20 Jan 2015 Current
Rachana Khatri Director 18 Oct 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 20 Jan 2015 Past
Pramod Abcsdd Additional Director 19 Nov 2018 Past
Pramod Abcsdd Director 20 Jan 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Maxzimaa Pharmaceuticals.

Maxzimaa Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.08% increase. The company also saw a substantial improvement in profitability, with a 2425.57% increase in profit. The company's net worth moved up by a moderate rise of 1.65%.

Maxzimaa Pharmaceuticals revenue growth over time
Maxzimaa Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 36.08%
*******
*******
*******
*******
Revenue from Operations
*******
 46.50%
*******
*******
*******
*******
Total Assets
*******
 44.53%
*******
*******
*******
*******
Profit or Loss
*******
 2425.57%
*******
*******
*******
*******
Net Worth
*******
 1.65%
*******
*******
*******
*******
EBITDA
*******
 181.84%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Maxzimaa Pharmaceuticals?

In 2023, Maxzimaa Pharmaceuticals had a public holding of 96.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹4,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.45 Cr
Latest Charge Details
Date Lender Amount Status
28 Mar 2025 Others ₹4.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Maxzimaa Pharmaceuticals?

Maxzimaa Pharmaceuticals has a workforce of 57 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Maxzimaa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxzimaa Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Maxzimaa Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Maxzimaa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Maxzimaa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.

  • Charges

    The activity A charge with Others amounted to Rs. 4.50 M with Charge ID 101095026 was registered on 28 Mar 2025. was completed.

  • Director Appointment

    The activity Rachana Khatri was appointed as a Director was appointed as a Director on 18 Oct 2018 & has been associated with this company since 7 years 4 months . was completed.

  • Director Appointment

    The activity Sucheta Dhawan was appointed as a Director was appointed as a Director on 20 Jan 2015 & has been associated with this company since 11 years 1 month . was completed.

  • Director Appointment

    Dhiraj Joshi was appointed as a Director was appointed as a Director on 20 Jan 2015 & has been associated with this company since 11 years 1 month . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Maxzimaa Pharmaceuticals Private Limited?

The CIN of Maxzimaa Pharmaceuticals Private Limited is U24100DL2014PTC274793.

Where is Maxzimaa Pharmaceuticals Private Limited headquartered?

Maxzimaa Pharmaceuticals Private Limited is headquartered at 403, Amber Tower, 4Th Floor, Azadpur Commercial Complex,, Azadpur, Delhi, 110033.

When was Maxzimaa Pharmaceuticals Private Limited incorporated?

Maxzimaa Pharmaceuticals Private Limited was incorporated on 30 December 2014.

Who are the current directors of Maxzimaa Pharmaceuticals Private Limited?

The current directors of Maxzimaa Pharmaceuticals Private Limited are

What is the primary industry of Maxzimaa Pharmaceuticals Private Limited?

The primary industry of Maxzimaa Pharmaceuticals Private Limited is Trade.

Is Maxzimaa Pharmaceuticals Private Limited a listed company?

Maxzimaa Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Maxzimaa Pharmaceuticals Private Limited?

The authorized capital of Maxzimaa Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹2.50 M.

What is the compliance status of Maxzimaa Pharmaceuticals Private Limited?

The compliance status of Maxzimaa Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available